argenx SE (ARGX)
981.33
+3.75
(+0.38%)
USD |
NASDAQ |
Nov 12, 16:00
980.52
-0.81
(-0.08%)
After-Hours: 20:00
argenx Max Drawdown (5Y) : 38.20% for Oct. 31, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2026 | 38.20% |
| September 30, 2026 | 38.20% |
| August 31, 2026 | 38.20% |
| July 31, 2026 | 38.20% |
| June 30, 2026 | 38.20% |
| May 31, 2026 | 38.20% |
| April 30, 2026 | 38.20% |
| March 31, 2026 | 38.20% |
| February 28, 2026 | 38.20% |
| January 31, 2026 | 38.20% |
| December 31, 2025 | 38.20% |
| November 30, 2025 | 38.20% |
| October 31, 2025 | 38.20% |
| September 30, 2025 | 38.20% |
| August 31, 2025 | 38.20% |
| July 31, 2025 | 38.20% |
| June 30, 2025 | 38.20% |
| May 31, 2025 | 38.20% |
| April 30, 2025 | 38.20% |
| March 31, 2025 | 38.20% |
| February 28, 2025 | 38.20% |
| January 31, 2025 | 38.20% |
| December 31, 2024 | 38.20% |
| November 30, 2024 | 38.20% |
| October 31, 2024 | 38.20% |
| Date | Value |
|---|---|
| September 30, 2024 | 38.20% |
| August 31, 2024 | 38.20% |
| July 31, 2024 | 38.20% |
| June 30, 2024 | 38.20% |
| May 31, 2024 | 38.20% |
| April 30, 2024 | 38.20% |
| March 31, 2024 | 38.20% |
| February 29, 2024 | 38.20% |
| January 31, 2024 | 38.20% |
| December 31, 2023 | 38.20% |
| November 30, 2023 | 34.13% |
| October 31, 2023 | 34.13% |
| September 30, 2023 | 36.29% |
| August 31, 2023 | 36.29% |
| July 31, 2023 | 36.29% |
| June 30, 2023 | 36.29% |
| May 31, 2023 | 36.29% |
| April 30, 2023 | 36.29% |
| March 31, 2023 | 36.29% |
| February 28, 2023 | 36.29% |
| January 31, 2023 | 36.29% |
| December 31, 2022 | 36.29% |
| November 30, 2022 | 36.29% |
| October 31, 2022 | 36.29% |
| September 30, 2022 | 36.29% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Autolus Therapeutics Plc | 96.58% |
| Cellectis SA | 97.08% |
| Halozyme Therapeutics, Inc. | 49.06% |
| DBV Technologies SA | 98.19% |
| Akari Therapeutics Plc | 99.83% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | 16.38 |
| Beta (5Y) | 0.4845 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 34.51% |
| Historical Sharpe Ratio (5Y) | 0.5899 |
| Historical Sortino (5Y) | 1.121 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 11.67% |